Centre for preventive medicine and physical activity of the Montreal Heart Institute (Centre ÉPIC)
Montreal, Quebec, H1T 1N6, Canada
NCT Number: NCT02048696
Patients who have suffered a heart attack are at risk of developing worsening heart function and heart failure. Exercise training has a beneficial effect on heart function and prevents heart failure. The aim of the current study is to investigate the effect of exercise training on heart function in patients who have suffered a heart attack.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Montreal, Quebec, H1T 1N6, Canada
Patients who have suffered a myocardial infarction are at significant risk for developing heart failure and progressive left ventricular dysfunction One of the proposed mechanisms responsible for this observation is reduction in myocardial beta-adrenergic receptor density due to elevated cell membrane protein G - protein coupled receptor kinase -2 (GRK2).
It is known that exercise training preserves heart function in patients who have suffered a myocardial infarction. The mechanism for this is not clear.
The purpose of this study is to examine the effect of exercise training on myocardial function and GRK2 levels in patients who have suffered a myocardial infarction, with the hypothesis that exercise training in this population reduces GRK2 levels and preserves or improves myocardial function.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Secondary prevention and cardiac rehabilitation clinic of the Montreal Heart Institute. Subjects will undergo twice weekly exercise training with high intensity interval training for a period of 12 weeks.
Time frame: at baseline and following 12 weeks exercise training intervention
change in lymphocyte GRK2 mRNA levels
Time frame: at baseline and following 12 weeks exercise training intervention
change in left ventricular systolic function
Time frame: at baseline and following 12 weeks exercise training intervention
Change in left ventricular dimensions
Time frame: at baseline and following 12 weeks exercise training intervention
change in plasma epinephrine
Time frame: at baseline and following 12 weeks exercise training intervention
change change in autonomic tone
Time frame: at baseline and following 12 weeks exercise training intervention
Change before and after exercise training
Time frame: at baseline and following 12 weeks exercise training intervention
Change in awake and 24h blood pressure
Time frame: at baseline and following 12 weeks exercise training intervention
change in plasma brain naturietic peptide
Time frame: at baseline and following 12 weeks exercise training intervention
change in maximal cardiac output and stroke volume
Time frame: at baseline and following 12 weeks exercise training intervention
change in lymphocyte GRK2 protein levels
Time frame: at baseline and following 12 weeks exercise training intervention
change in fasting glucose
Time frame: at baseline and following 12 weeks exercise training intervention
change in serum lipids
Montreal Heart Institute
Other
Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction: The EXercise Interval Training - V Study
Acronym: EXIT-V
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03646760
Angina Pectoris, Arterial Occlusive Diseases
Detroit, Michigan, United States
View Trial DetailsNCT03854071
Arterial Occlusive Diseases, Arteriosclerosis
Sheffield, England, United Kingdom
View Trial DetailsNCT00005487
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT02596087
Actinomycetales Infections, Anemia
Boston, Massachusetts, United States
View Trial Details